Patients with LORA and CLD at baseline had lower rates of treatment response and a higher risk for SAEs over 5 years, compared against those without CLD.

The Truvaga Plus claims to relieve stress, improve sleep, and clear brain fog — but does it really deliver? We tested it out.

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

A remote monitoring program predicted when patients with asthma would experience distress, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy ...

Pulmonary rehabilitation significantly improves physical capacity, lung function, and quality of life in long COVID patients, with the greatest benefits seen in 4-8 week programs combining breathing ...